AAAAAA

   
Results: 1-10 |
Results: 10
INTENSIFIED ALTERNATING CHEMOTHERAPY (CT) AND RADIOTHERAPY (RT) FOR STAGE-III-IV HEAD-AND-NECK-CANCER (HNC) PATIENTS (PTS)
Authors: BRAIN E SOULIE P DELALANDE B BERNARD A BANAL A MAHE E CVITKOVIC F ROUESSE J RAMBERT P
Citation: E. Brain et al., INTENSIFIED ALTERNATING CHEMOTHERAPY (CT) AND RADIOTHERAPY (RT) FOR STAGE-III-IV HEAD-AND-NECK-CANCER (HNC) PATIENTS (PTS), Annals of oncology, 9, 1998, pp. 365-365
OXALIPLATIN CISPLATIN (L-OHP/CDDP) COMBINATION IN HEAVILY PRETREATED OVARIAN-CANCER/
Authors: SOULIE P BENSMAINE A GARRINO C CHOLLET P BRAIN E FERERES M JASMIN C MUSSET M MISSET JL CVITKOVIC E
Citation: P. Soulie et al., OXALIPLATIN CISPLATIN (L-OHP/CDDP) COMBINATION IN HEAVILY PRETREATED OVARIAN-CANCER/, European journal of cancer, 33(9), 1997, pp. 1400-1406
CLINICAL AND PATHOLOGICAL RESPONSE TO PRIMARY CHEMOTHERAPY IN OPERABLE BREAST-CANCER
Authors: CHOLLET P CHARRIER S BRAIN E CURE H VANPRAAGH I FEILLEL V DELATOUR M DAUPLAT J MISSET JL FERRIERE JP
Citation: P. Chollet et al., CLINICAL AND PATHOLOGICAL RESPONSE TO PRIMARY CHEMOTHERAPY IN OPERABLE BREAST-CANCER, European journal of cancer, 33(6), 1997, pp. 862-866
SCHEDULE-DEPENDENT PACLITAXEL TOLERANCE ACTIVITY - DATA FROM A 7 DAY INFUSION PHASE-I STUDY WITH PHARMACOKINETICS IN PACLITAXEL REFRACTORY OVARIAN-CANCER/
Authors: SOULIE P TRANDAFIR L TAAMMA A LOKIEC F BRAIN E DELORD JP MITA A VANNETZEL JM CVITKOVIC E MISSET JL
Citation: P. Soulie et al., SCHEDULE-DEPENDENT PACLITAXEL TOLERANCE ACTIVITY - DATA FROM A 7 DAY INFUSION PHASE-I STUDY WITH PHARMACOKINETICS IN PACLITAXEL REFRACTORY OVARIAN-CANCER/, Anti-cancer drugs, 8(8), 1997, pp. 763-766
HIGH-DOSE METHOTREXATE AND CEREBRAL NEURO TOXICITY - A CASE OF ARACHNOIDITIS
Authors: BRAIN E ALEXANDRE J MINOZZI C MISSET JL
Citation: E. Brain et al., HIGH-DOSE METHOTREXATE AND CEREBRAL NEURO TOXICITY - A CASE OF ARACHNOIDITIS, La Presse medicale, 26(6), 1997, pp. 265-268
LONG-TERM PROGNOSTIC AND PREDICTIVE FACTORS IN 107 STAGE-II STAGE-IIIBREAST-CANCER PATIENTS TREATED WITH ANTHRACYCLINE-BASED NEOADJUVANT CHEMOTHERAPY/
Authors: BRAIN E GARRINO C MISSET JL CARBONERO IG ITZHAKI M CVITKOVIC E GOLDSCHMIDT E BURKI F REGENSBERG C PAPPO E HAGIPANTELLI R MUSSET M
Citation: E. Brain et al., LONG-TERM PROGNOSTIC AND PREDICTIVE FACTORS IN 107 STAGE-II STAGE-IIIBREAST-CANCER PATIENTS TREATED WITH ANTHRACYCLINE-BASED NEOADJUVANT CHEMOTHERAPY/, British Journal of Cancer, 75(9), 1997, pp. 1360-1367
5-FLUOROURACIL CARDIOTOXICITY - A UNIQUE MECHANISM FOR ISCHEMIC CARDIOPATHY AND CARDIAC-FAILURE
Authors: LIEUTAUD T BRAIN E GOLGRANTOLEDANO D VINCENT TF CVITKOVIC E LECLERCQ B ESCUDIER B
Citation: T. Lieutaud et al., 5-FLUOROURACIL CARDIOTOXICITY - A UNIQUE MECHANISM FOR ISCHEMIC CARDIOPATHY AND CARDIAC-FAILURE, European journal of cancer, 32A(2), 1996, pp. 368-369
PATHOPHYSIOLOGY AND THERAPY OF IRINOTECAN (CPT-11) INDUCED DELAYED-ONSET DIARRHEA (DD) - A PROSPECTIVE ASSESSMENT
Authors: MISSET JL SALIBA F GIACCHETTI S BRAIN E VASSAL G BONNAY M BASTIAN G COTE C MAHJOUBI M HERAIT P HAGIPANTELLI R CVITKOVIC E
Citation: Jl. Misset et al., PATHOPHYSIOLOGY AND THERAPY OF IRINOTECAN (CPT-11) INDUCED DELAYED-ONSET DIARRHEA (DD) - A PROSPECTIVE ASSESSMENT, European journal of cancer, 31A, 1995, pp. 742-742
HIGH-DOSE IFOSFAMIDE - CIRCUMVENTION OF RESISTANCE TO STANDARD-DOSE IFOSFAMIDE IN ADVANCED SOFT-TISSUE SARCOMAS
Authors: LECESNE A ANTOINE E SPIELMANN M LECHEVALIER T BRAIN E TOUSSAINT C JANIN N KAYITALIRE L FONTAINE F GENIN J VANEL D CONTESSO G TURSZ T
Citation: A. Lecesne et al., HIGH-DOSE IFOSFAMIDE - CIRCUMVENTION OF RESISTANCE TO STANDARD-DOSE IFOSFAMIDE IN ADVANCED SOFT-TISSUE SARCOMAS, Journal of clinical oncology, 13(7), 1995, pp. 1600-1608
THE CARDIOTOXICITY OF VINORELBINE
Authors: RAYMOND E GOLDWASSER F ESPIE M BRAIN E CUVIER C EXTRA JM MARTY M
Citation: E. Raymond et al., THE CARDIOTOXICITY OF VINORELBINE, Cancer research, therapy & control, 4(2), 1994, pp. 87-88
Risultati: 1-10 |